Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.

[1]  E. Ciurczak.  Uses of near-infrared spectroscopy in pharmaceutical analysis , 1987 .

[2]  S. Ghodbane,et al.  Study of the polymorphism of 3-(((3-(2-(7-chloro-2-quinolinyl)-E)-ethenyl)phenyl)((3-(dimethylamino-3-oxopropyl)thio)methyl)-thio)propanoic acid (MK571) by DSC, TG, XRPD and solubility measurements , 1990 .

[3]  J. M. deMan,et al.  X-ray diffraction spectroscopy in the study of fat polymorphism , 1992 .

[4]  W Plugge,et al.  Near-infrared spectroscopy as an alternative to assess compliance of ampicillin trihydrate with compendial specifications. , 1993, Journal of pharmaceutical and biomedical analysis.

[5]  B. Pauvert,et al.  Infrared, raman, and 13C NMR spectra of two crystalline forms of (1R,3S)-3-(p-thioanisoyl)-1,2,2-trimethylcyclopentanecarboxylic acid. , 1994, Journal of pharmaceutical sciences.

[6]  S. Fujii,et al.  X-ray structural studies of lomeridine dihydrochloride polymorphs. , 1996, Journal of pharmaceutical sciences.

[7]  Karl-Artur Kovar,et al.  Strategies for Constructing Near-Infrared Spectral Libraries for the Identification of Drug Substances , 1997 .

[8]  Near infrared transmittance analysis for the assay of solid pharmaceutical dosage forms. , 1999, The Analyst.

[9]  D. Grant.  THEORY AND ORIGIN OF POLYMORPHISM , 1999 .

[10]  R. D. Jee,et al.  A rapid quantitative assay of intact paracetamol tablets by reflectance near-infrared spectroscopy. , 1999 .

[11]  M. Blanco,et al.  Polymorphic analysis of a pharmaceutical preparation by NIR spectroscopy. , 2000, The Analyst.